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Serotonin Transporter Gene Polymorphisms and Chronic Illness 
of Depression
Clinical course of depression is variable. The serotonin transporter gene is one of the most 
studied genes for depression. We examined the association of serotonin transporter gene 
polymorphisms with chronicity and recurrent tendency of depression in Korean subjects. 
This cross-sectional study involved 252 patients with major depression. Patients were 
genotyped for s/l polymorphisms in 5-HTT promoter region (5-HTTLPR), s/l variation in 
second intron of the 5-HTT gene (5-HTT VNTR intron2). Chronicity was associated with 
5-HTTLPR. Patients with l/l had higher rate of chronicity than the other patients (l/l vs s/l or 
s/s; odds ratio, 4.45; 95% confidence interval, 1.59-12.46; P=0.005; logistic regression 
analysis). Recurrent tendency was not associated with 5-HTTLPR. Chronicity and recurrent 
tendency were not associated with 5-HTT VNTR intron2. These results suggest that chronic 
depression is associated with 5-HTTLPR. 
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Major depressive disorder is one of the most common of the 
serious psychiatric disorder (1). Clinical course of depressive 
disorder is variable. It ranges from months to years and a single 
episode of illness to a recurrent episode (2). About 15-18% of 
patients with major depressive episode could not reach to re-
covery in the 2 yr after onset of depressive episode. And more 
than 50% of patients experience a recurrence in 5 yr (3).
  Chronic illness of depression has a considerable impact on 
social functioning, is difficult to treat and is associated with 
higher rates of history of suicide attempt (1, 4). And chronicity 
and risk of recurrence are strong predictors of the need for ag-
gressive use of maintenance therapy. Therefore an early identi-
fication of clinical course is of great importance (5).
  However, only a few factors have been shown to be associat-
ed with clinical course. Especially the genetic factors that influ-
ence the clinical course are remained unclear despite the heri-
tability that has been shown by family studies (6, 7).
  The serotonin transporter gene is one of the most studied 
genes for depression. Previous studies showed that polymor-
phisms in the serotonin transporter gene may influence antide-
pressant response (8, 9), neuroticism (10) and hippocampus 
volume (11) in depressive patients. 
  Although many phenotypes of serotonin transporter gene 
were investigated, there are few studies about clinical course. A 
retrospective study showed 5-HTTLPR polymorphisms were 
not associated with mood disorders time course (12). However 
they excluded chronic depression. A population-based study of 
major depressive disorder showed association of 5-HTTLPR 
and durations of episode (13). However no replication results 
were reported in an Asian population. Furthermore they esti-
mated the duration of episodes in quantitative traits, not quali-
tative traits. Therefore, association between 5-HTT gene poly-
morphism and chronicity was still unclear.
  We examined the association of serotonin transporter gene 
polymorphisms with the chronic illness of depression in Kore-
an subjects. All subjects were of unrelated Korean ancestry. Eli-
gible patients were enrolled in the Clinical Trials Program of the 
Samsung Medical Center Geropsychiatry and Affective Disor-
der Clinics (Seoul, Korea). Entry criteria were: at least 18 yr of 
age, unipolar major depressive episode by DSM-IV criteria, at 
least 2 yr after first episode onset, agreement to informed con-
sent. Exclusion criteria were: pregnancy, significant medical 
conditions, abnormal laboratory baseline values, unstable psy-
chiatric feature (e.g., suicidal attempt), history of alcohol or drug Myung W, et al.  •  Serotonin Transporter Gene Polymorphisms and Chronic Illness of Depression
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dependence, seizures, neurological illness or concomitant Axis 
I psychiatric disorder. A total of 252 patients were enrolled. This 
study was approved by the Institutional Review Board of the 
Samsung Medical Center (IRB number 2005-09-068).
  At entry, all patients received a semistructured diagnostic in-
terview, the Samsung Psychiatric Evaluation Schedule (14) for 
diagnostic evaluation and clinical data collection. The SPES pro-
vides information about psychiatric symptoms, comorbid psy-
chiatric diagnoses, and psychosocial variables (age, sex, age of 
onset, duration of current episode, episode number, family his-
tory and initial Hamilton Rating Scale for Depression [HAM-D]). 
Clinical data was collected by structured interview with patient 
and at least 1 family member. Psychiatric diagnoses were con-
firmed by a board-certified psychiatrist. 
  We classified the chronic illness into two categories; chronic-
ity and recurrent tendency. Defining depressions as chronic and 
non-chronic is arbitrary nature of the cutoff point. Furthermore 
definitions of chronic depression also differ with respect to se-
verity and pattern. The DSM-IV includes a number of categories 
and specifiers for chronic depression; chronic depressive epi-
sode, dysthymic disorder, major depressive episode with ante-
cedent dysthymia and current major depression with incom-
plete interepisode recovery. In this study chronicity was defined 
as duration of current episode was not less than 24 months ac-
cording to DSM-IV criteria of chronic depressive episode. We 
excluded another categories for chronic depression; dysthymic 
disorder, major depressive episode with antecedent dysthymia 
and current major depression with incomplete interepisode re-
covery.
  And a cohort study showed that patients who have a history 
of three or more episodes has shorter inter-episode interval than 
those with a first time onset of unipolar major depression (15). 
Based on this evidence, recurrent tendency was defined as no 
fewer than 2 episodes in this study. We defined recurrence as 
occurring of another episode with interepisode recovery. The 
definition of depressive episode was defined as DSM-IV criteria.
  Patients were genotyped for short/long (s/l) polymorphisms 
in 5-HTT promoter region (5-HTTLPR), s/l variation in second 
intron of the 5-HTT gene (5-HTT VNTR intron2). Genomic DNA 
was extracted from whole blood and 5-HTT genotyping was per-
formed essentially as described previously (14). 
  In statistical analysis, means and standard deviations of con-
tinuous variables and proportions of categorical variables were 
presented as descriptive statistics. The Mann-Whitney U test was 
used for continuous variables when they were not normally dis-
tributed and chi-square test was used for categorical variables. 
Hardy-Weinberg equilibrium was tested by chi-square test. Lo-
gistic regression model, with appropriate covariates (chronicity: 
sex, age; recurrent tendency: sex, age, age of onset), was used to 
evaluate the association of independent variables with the chro-
nicity and the recurrent tendency. Result were considered sig-
nificant at P value <0.05. All statistical analyses were performed 
using STATA 10.0 for Windows.
  Clinical and demographic characteristics are shown in Table 
1. There were no major differences between patients with chro-
nicity and the other patients with sex, age, age of onset, initial 
HAM-D scores and first degree family history. There were no 
notable differences between patients with recurrent tendency 
and the other patients with sex, age and initial HAM-D. But pa-
tients with recurrent tendency showed earlier age of onset (43.3 
vs 53.0, P<0.001) and higher rate of first degree family history. 
(30.3% vs 18.3%, P=0.027)
  Among the subjects, 19.3% of subjects had chronicity and 
39.3% of subjects had recurrent tendency. Only 8% of patients 
with recurrent tendency had chronicity and 22% of patients with 
chronicity had recurrent tendency.
  The 5-HTTLPR and the 5-HTT VNTR intron2 genotypes were 
distributed according to the Hardy-Weinberg equilibrium. Chro-
Table 1. Characteristics of study patients and distribution according to genotypes
Characteristics/Genotypes Overall
Chronicity (Duration of Current Episode) Recurrent Tendency (Number of Episode)
≥24 months <24 months P value ≥3 <3 P value
Total
†
   Male
   Female
252
  56
196
  9
27
  47
169
0.67
18
81
  38
115
0.22
Age* (yr) 62.5 (54.5-69) 59 (51.5-66.5) 63 (55-69) 0.24 64 (55-71) 61 (54-68) 0.26 
Age of Onset* (yr) 52 (40-60) 45 (38.5-58) 52 (40-60) 0.27 43 (30-55) 55 (45-61) <10-4
Initial HAM-D* 20 (17-24) 20 (18-23) 20 (17-24) 0.68 20 (17-23) 20 (17-24) 0.23
% 1st degree family history
† 23.02% 16.67% 24.07% 0.33 30.30% 18.30%   0.027
5-HTTLPR
‡
   l/l
   s/l plus s/s
  18
234
  7
29
  11
205
0.005  
[OR]=4.45  
(95% CI: 1.59-12.46)
  9
90
    9
144
0.29  
[OR]=1.79  
(95% CI: 0.60-5.28)
5-HTT VNTR intron2
‡
   l/l
   s/l plus s/s
206
  46
28
38
178
    8
0.48  
[OR]=0.73  
(95% CI: 0.31-1.74)
77
22
129
  24
0.32  
[OR]=0.68  
(95% CI: 0.32-1.45)
*The Mann-Whitney U test was used; Value is median (interquartile); 
†The χ2 test was used; 
‡Logistic regression analysis was used.
HAM-D, hamilton rating scale for depression score; 5-HTTLPR, serotonin transporter gene-linked polymorphic region; 5-HTT, serotonin transporter; OR, odds ratio; CI, confidence 
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nicity was associated with 5-HTTLPR. Patients with l/l had high-
er rate of chronic depression than the other patients (l/l vs s/l 
plus s/s; Odds ratio, 4.45; 95% confidence interval, 1.59-12.46; 
P=0.005). We calculated that the sample size gives 81% power 
at the 0.05 level of significance. However, chronicity was not as-
sociated with 5-HTT VNTR intron2. Recurrent tendency was 
not associated with 5-HTTLPR and 5-HTT VNTR intron2 (Table 
1). The study was not powered to detect significant associations 
with recurrent tendency and polymorphisms.
  In this study we investigated possible genetic predictors of 
chronicity and recurrent tendency of depression. The result indi-
cate that chronic depression is associated with 5-HTTLPR. How-
ever, recurrent tendency was not associated with 5-HTTLPR. 
Chronicity and recurrent tendency were not associated with 
5-HTT VNTR intron2. To the best of our knowledge, this is the 
first study of the association between the polymorphisms of se-
rotonin transporter and episode duration in Asian subjects.
  In the previous study that was conducted in American popu-
lation, individuals with 1 or 2 short alleles (s/l or s/s) had epi-
sodes that were about 20 weeks shorter (13). It was similar with 
the result of our study. Contrast with pharmacogenetic studies it 
showed that the association of episode duration and 5-HTTLPR 
has no ethnic difference (9, 16). Studies of 5-HTTLPR reported 
that in white populations, depressed patients with the short allele 
genotype (s/s) generally show a smaller response to selective 
serotonin reuptake inhibitors than those with a long allele (l/l 
and s/l). However, studies in Korean and Japanese population 
report an association in the opposite direction (8, 17). It suggests 
the possibility of different mechanism of genetic influence to 
chronicity and drug response. 
  In our data only 8% of patients with recurrent tendency had 
chronicity and 22% of patients with chronicity had recurrent 
tendency. Moreover, 5-HTTLPR was associated with chronicity 
and has no association with recurrent tendency. This inconsis-
tent result between chronicity and recurrent tendency suggests 
the genetic difference of chronic depression and recurrent de-
pression. However, our study was not powered to detect signifi-
cant associations with recurrent tendency and polymorphisms. 
The further genetic investigations were needed to reveal the re-
lationship between chronic depression and recurrent depres-
sion.
  The major limitation of our study is its retrospective approach 
of clinical course. Recall bias could affect detection of past epi-
sode and duration of illness. Lack of adequate clinical informa-
tion is notable limitation. Our study did not include the whole 
clinical course. The past episode durations and the natural course 
of current episode were not assessed. And past medication and 
antidepressant response history were not included in the anal-
ysis. In addition, we have little consideration on psychosocial 
factors despite its influence on mental illness (18). Another lim-
itation is the generalizability of study finding. Our participants 
were mostly elderly, and most had late-onset illness. Despite 
these limitations, this study demonstrates the significant asso-
ciation of genetic factor and chronicity of depression.
  In conclusion, we examined the association of serotonin trans-
porter gene polymorphisms with the chronicity and the recur-
rent tendency of depression in Korean subjects. These results 
suggest that chronic depression is associated with 5-HTTLPR. 
Confirmation of this preliminary finding would help to predict 
the clinical course of depression by genetic evaluation.
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